Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
Study NCT ID:
NCT07370766
Status:
RECRUITING
Last Update Posted:
2026-01-27
First Post:
2026-01-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada
Sponsor:
Chronicle Academy
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-25
Start Date Type:
ACTUAL
Primary Completion Date:
2027-05-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-05-30
Completion Date Type:
ESTIMATED
First Submit Date:
2026-01-12
First Submit QC Date:
None
Study First Post Date:
2026-01-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-01-20
Last Update Post Date:
2026-01-27
Last Update Post Date Type:
ACTUAL